Virtus LifeSci Valuation Overview

BBC -- USA Etf  

USD 33.75  0.16  0.47%

Virtus LifeSci Biotech has current Real Value of $33.7 per share. The regular price of the etf is $33.75. At this time the etf appears to be fairly valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 347, Net Asset of 77.99M and Price to Earning of 39.87times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Clinical Trls ETF is second largest ETF in price to earning as compared to similar ETFs. It is the top ETF in one year return as compared to similar ETFs reporting about  1.69  of One Year Return per Price to Earning.

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries
Fairly Valued
July 19, 2018
33.75
Market Value
33.70
Real Value
Target Odds
  
38.23
Upside
Virtus LifeSci is not too volatile asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.